These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6191046

  • 1. Epidermal growth factor is not the major growth-promoting agent in extracts of prostatic tissue.
    Story MT, Jacobs SC, Lawson RK.
    J Urol; 1983 Jul; 130(1):175-9. PubMed ID: 6191046
    [Abstract] [Full Text] [Related]

  • 2. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F.
    Ann N Y Acad Sci; 1995 Jun 12; 761():66-78. PubMed ID: 7542859
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
    Lubrano C, Toscano V, Petrangeli E, Spera G, Trotta MC, Rombolà N, Frati L, Di Silverio F, Sciarra F.
    J Steroid Biochem Mol Biol; 1993 Oct 12; 46(4):463-8. PubMed ID: 7692939
    [Abstract] [Full Text] [Related]

  • 6. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB, Kudlow JE, Grizzle WE.
    Mod Pathol; 1993 Nov 12; 6(6):733-7. PubMed ID: 7508115
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P, Royuela, Bethencourt R, Ruiz A, Fraile B, Paniagua R.
    Cytokine; 1999 Sep 12; 11(9):722-7. PubMed ID: 10479409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods.
    Maddy SQ, Chisholm GD, Hawkins RA, Habib FK.
    J Endocrinol; 1987 Apr 12; 113(1):147-53. PubMed ID: 2438365
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor, epidermal growth factor receptor, and transforming growth factor-alpha in human hyperplastic prostate tissue: expression and cellular localization.
    De Bellis A, Ghiandi P, Comerci A, Fiorelli G, Grappone C, Milani S, Salerno R, Marra F, Serio M.
    J Clin Endocrinol Metab; 1996 Nov 12; 81(11):4148-54. PubMed ID: 8923874
    [Abstract] [Full Text] [Related]

  • 15. [Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer].
    Janssen T, Kiss R, Schulman C.
    Acta Urol Belg; 1995 Mar 12; 63(1):7-14. PubMed ID: 7537011
    [Abstract] [Full Text] [Related]

  • 16. Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate.
    Davies P, Eaton CL.
    Prostate; 1989 Mar 12; 14(2):123-32. PubMed ID: 2469072
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostatic epidermal growth factor receptors and their regulation by androgens.
    Traish AM, Wotiz HH.
    Endocrinology; 1987 Oct 12; 121(4):1461-7. PubMed ID: 3498628
    [Abstract] [Full Text] [Related]

  • 19. Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?
    Di Silverio F, Sciarra A, Monti S, Casale P, Seccareccia F.
    J Urol; 1999 Jan 12; 161(1):128-32. PubMed ID: 10037384
    [Abstract] [Full Text] [Related]

  • 20. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N, Karyotis I, Delakas D, Spandidos DA.
    Int J Oncol; 2006 Aug 12; 29(2):305-14. PubMed ID: 16820871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.